Epac1 inhibition ameliorates pathological angiogenesis through coordinated activation of Notch and suppression of VEGF signaling Journal Article


Authors: Liu, H.; Mei, F. C.; Yang, W.; Wang, H.; Wong, E.; Cai, J.; Toth, E.; Luo, P.; Li, Y. M.; Zhang, W.; Cheng, X.
Article Title: Epac1 inhibition ameliorates pathological angiogenesis through coordinated activation of Notch and suppression of VEGF signaling
Abstract: In this study, we investigated the roles of Epac1 in pathological angiogenesis and its potential as a novel therapeutic target for the treatment of vasoproliferative diseases. Genetic deletion of Epac1 ameliorated pathological angiogenesis in mouse models of oxygen-induced retinopathy (OIR) and carotid artery ligation. Moreover, genetic deletion or pharmacological inhibition of Epac1 suppressed microvessel sprouting from ex vivo aortic ring explants. Mechanistic studies revealed that Epac1 acted as a previously unidentified inhibitor of the γ-secretase/ Notch signaling pathway via interacting with γ-secretase and regulating its intracellular trafficking while enhancing vascular endothelial growth factor signaling to promote pathological angiogenesis. Pharmacological administration of an Epac-specific inhibitor suppressed OIR-induced neovascularization in wild-type mice, recapitulating the phenotype of genetic Epac1 knockout. Our results demonstrate that Epac1 signaling is critical for the progression of pathological angiogenesis but not for physiological angiogenesis and that the newly developed Epac-specific inhibitors are effective in combating proliferative retinopathy. Copyright © 2020 The Authors.
Keywords: signaling; vascular endothelial growth factor; mammals; therapeutic targets; eye protection; intracellular trafficking; blood vessels; pharmacological inhibition; notch signaling pathways; specific inhibitors; neo-vascularization; oxygen induced retinopathies
Journal Title: Science Advances
Volume: 6
Issue: 1
ISSN: 2375-2548
Publisher: Amer Assoc Advancement Science  
Date Published: 2020-01-01
Start Page: eaay3566
Language: English
DOI: 10.1126/sciadv.aay3566
PUBMED: 31911948
PROVIDER: scopus
PMCID: PMC6938696
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yueming Li
    132 Li
  2. Wan Fung Wong
    12 Wong